IMAC Holdings Research and Development Expenses 2018-2024 | BACK
IMAC Holdings research and development expenses from 2018 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
IMAC Holdings Annual Research and Development Expenses (Millions of US $) |
2023 |
$ |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
IMAC Holdings Quarterly Research and Development Expenses (Millions of US $) |
2024-03-31 |
|
2023-12-31 |
|
2023-09-30 |
|
2023-06-30 |
|
2023-03-31 |
|
2022-12-31 |
|
2022-09-30 |
|
2022-06-30 |
|
2022-03-31 |
|
2021-12-31 |
|
2021-09-30 |
|
2021-06-30 |
|
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
|
2018-12-31 |
$0 |
2018-09-30 |
|
2018-06-30 |
|
2018-03-31 |
|
2017-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.001B |
$0.016B |
IMAC Holdings Inc. is a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids. It owns or manages outpatient clinics which provide regenerative, orthopedic and minimally invasive procedures and therapies. The company's outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids. IMAC Holdings Inc. is based in BRENTWOOD TN.
|